Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES USA: Oligonucleotide & Peptide Therapeutics
April 26-29, 2027
Hynes Convention CenterBoston, MA

Pedro Gautier
Director of Process Validation at Agilent Technologies
Speaker

Profile

Pedro J. Gautier is a seasoned pharmaceutical leader with over 25 years of experience in process validation, CMC strategy, and GMP manufacturing. Currently serving as Process Validation Director at Agilent Technologies, he leads validation programs supporting commercial oligonucleotide API manufacturing. Throughout his career, Pedro has guided cross-functional teams through Stage 1–3 validation, regulatory submissions, and PPQ execution across biologics and advanced therapeutics. He previously held leadership roles at Novavax, Boehringer Ingelheim, Thermo Fisher Scientific, and Amgen. Pedro is recognized for building high-performing teams, implementing risk-based validation strategies, and delivering inspection-ready, science-driven solutions that accelerate commercialization while maintaining rigorous quality and compliance standards

Agenda Sessions

  • Validation Without the Guesswork: A Fit-for-Purpose Strategy for Oligonucleotide Manufacturing

    9:00am